Drugs.com - FDA MedWatch Alerts

Provepharm Inc. Issues Recall of One Lot of Phenylephrine Hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk Package) Due to Presence of Particulate Matter

Audience: Pharmacy, Consumer January 24, 2025 – Collegeville, Pennsylvania, Provepharm Inc. is voluntarily recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk...

Apr 26, 2025 - 14:23
 0
Provepharm Inc. Issues Recall of One Lot of Phenylephrine Hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk Package) Due to Presence of Particulate Matter
Audience: Pharmacy, Consumer January 24, 2025 – Collegeville, Pennsylvania, Provepharm Inc. is voluntarily recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk...
Read More

Tags:

Previous Article

Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal S...

Next Article

Drug Safety Communication: Copaxone, Glatopa (glatiramer acetate) - FDA Adds Box...

Related Posts

VitalityVita Issues Voluntary Nationwide Recall of VitalityXtra and PeakMax Capsules Due to the Presence of Undeclared Sildenafil and Diclofenac

VitalityVita Issues Voluntary Nationwide Recall of Vita...

Apr 26, 2025  0

FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize

FDA Clarifies Policies for Compounders as National GLP-...

Apr 26, 2025  0

FDA Adds Boxed Warning to Veozah (fezolinetant) to Highlight the Known Risk of Rare But Serious Liver Injury

FDA Adds Boxed Warning to Veozah (fezolinetant) to High...

Apr 26, 2025  0